Blood Cancer Institute Research
This Blood Cancer Institute’s highly collaborative program among experts in basic science and translational and clinical research at Montefiore Einstein Comprehensive Cancer Center is speeding the pathway from lab breakthrough to promising therapies and even cures for blood cancers. The search for new treatment options for people with lymphoma, leukemia, MDS, myeloma and other blood cancers is intensive and fast-paced.
The Institute kick-starts the early stages of both basic and translational research, when outcomes are less certain. We will focus on areas where we can make a unique contribution to the field–basic bench research and also early-phase clinical trials with novel compounds, for instance. Then we can take the next step and bring the state-of-the-art science into the clinic.
Amit Verma, MD
Select Research Published to Date
The robust output of high-impact research publications in the past several years is just one measure of the Institute’s productivity.
Konopleva M, Timothy A, Daver N, et al. Complex I Inhibitor of Oxidative Phosphorylation in Advanced Solid Tumors and Acute Myeloid Leukemia: Phase I Trials. Nat Med. 2022; pre-print: https://doi.org/10.21203/rs.3.rs-1506700/v1
Learn More & Join Us in the Search for Cures
More about our fundamental discoveries into the mechanisms of blood cancers is available on our basic research pages. And details about our clinical work, including numerous Investigator-Initiated Trials in blood cancers, appears in our translational and clinical research section.
We welcome you to our initiative, and hope you’ll consider making a donation to help support our work.